Omalizumab for the management of refractory chronic spontaneous urticaria
Chronic spontaneous urticaria (CSU) is a heterogeneous, systemic, primarily mast cell-driven disease with sudden appearance of wheals with or without angioedema with pruritus for more than 6 weeks. It affects 0.3%–0.6% of the general population. CSU is a complex immune-mediated disease due to induct...
| Published in: | Indian Journal of Allergy Asthma and Immunology |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Subjects: | |
| Online Access: | http://www.ijaai.in/article.asp?issn=0972-6691;year=2022;volume=36;issue=2;spage=65;epage=72;aulast=Kathuria |